Exchange: NYSEArca·Updated 07:30 PM EDT
News
all
press releases
Microsoft, Meta, Comcast and Biogen rise premarket; Qualcomm falls
Investing.com -- U.S. stock futures rose sharply Thursday, with investors digesting earnings from a couple of tech giants, the Federal Reserve policy decision and more labor market data.
investing.com
More News
Humana stock falls after losing Medicare bonus payment lawsuit
Investing.com -- Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted other health insurers, with CVS Health (NYSE:CVS) and UnitedHealth Group (NYSE:UNH) shares declining 2%.
investing.com
Centene stock tumbles after withdrawal of 2025 guidance
Investing.com -- Centene Corporation (NYSE:CNC) stock tumbled 20% after the health insurer withdrew its 2025 earnings guidance, citing unexpected challenges in its Health Insurance Marketplace business and rising Medicaid costs.
investing.com
Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle
Investing.com -- Mizuho has updated its U.S. Top Picks list for June, adding CVS Health (NYSE:CVS), PayPal (NASDAQ:PYPL) and Oracle (NYSE:ORCL) to its highest-conviction ideas, alongside ConocoPhillips (NYSE:COP), First Solar (NASDAQ:FSLR), Insmed (NASDAQ:INSM), Corteva (NYSE:CTVA), and Carrier Global (NYSE:CARR). 
investing.com
UnitedHealth, Humana, CVS drop on expanded Medicare Advantage audits
Investing.com -- Shares of major health insurers UnitedHealth (NYSE:UNH), Humana (NYSE:HUM), and CVS (NYSE:CVS) fell sharply today, with UnitedHealth down 4%, Humana declining 5%, and CVS dropping 4% in afterhours trading. The slide came in response to the Centers for Medicare&Medicaid Services (CMS) announcing a significant expansion of its auditing efforts for Medicare Advantage (MA) plans.
investing.com
Bernstein says market overreacting to Trump order, sees limited new impact on PBMs
Investing.com -- Bernstein analysts say the market has overreacted to President Trump’s latest executive order on drug pricing, arguing that the directive poses limited new risks to pharmacy benefit managers (PBMs) despite a sharp selloff in the sector.
investing.com
CVS Health reward 'positively skewed'
Investing.com -- CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from Market Perform to Outperform and raise its price target to $75 per share in a note Thursday. 
investing.com
CVS Health quarterly earnings top estimates amid turnaround push
Investing.com - CVS Health (NYSE:CVS) has posted better-than-anticipated income and revenue in the fourth quarter, as the healthcare group pursues a broad overhaul of its operations under new Chief Executive David Joyner.
investing.com
FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down
Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty generic drugs, according to a new interim staff report.
investing.com

Advertisement|Remove ads.